Completed
Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis
NCT01981161
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +19 more
- Locations
-
- CHU Besançon Besançon, France
- CHU Bordeaux Bordeaux, France
- CHU Caen Caen, France
- Chu Lille Lille, France